<a href="https://laohu8.com/S/TWST">Twist Bioscience</a> Appoints Trynka Shineman Blake to Board of Directors, Enhancing Strategic Growth and Customer Experience Initiatives
Twist Bioscience Corporation has announced the appointment of Trynka Shineman Blake to its board of directors. She will also serve on the audit committee. Ms. Shineman Blake, who previously served as CEO of Vistaprint, brings extensive experience in corporate governance, customer experience, and digital transformation. Her appointment is expected to contribute to Twist Bioscience's strategic direction and growth as the company works towards achieving adjusted EBITDA breakeven and delivering innovative solutions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twist Bioscience Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250806218674) on August 06, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。